In a shocking incident, it has been revealed that the world’s biggest drug company, Pfizer, has summoned up in excess of 1 million packs of contraceptive pills following a recent disclosure in which it was revealed that the birth-control pills were muddled up in packs. As a result, claims are being made that a large number of women might be at the risk of unwanted or unintended pregnancy.

As per reports, it has been revealed that the Food and Drug Administration (FDA) has given a green signal to Pfizer for its new oral treatment INLYTA. The oral drug is meant for patients who have been suffering from advanced Renal Cell Carcinoma (RCC).

As per the data released by IMS on Monday, it has been revealed that in excess of 476,000 fresh prescriptions in context of generic Lipitor, mainly dubbed as atorvastatin, were to the top right through the week ended on December 9. In addition, it has been found that almost 80% prescriptions were meant for the generic version of Watson.

Is one of the world's biggest drug companies following spurious means to escalate its profits? Perhaps that's what Australian pharmacists by and large believe in. It has been told that as per a deal signed between Pfizer and Pharmacy Guild of Australia in July, Pfizer would pay pharmacies $7 as administration fee in lieu of getting a patient signed up for their much touted support program.

The National Pharmaceutical Services Association has organised "No Monopoly on Medicines" movement this year, after the declaration made by Pfizer who plans supply the medicines directly to retailers rather than getting it supplied through distributors.

While it has been quite some time that the Biocon and Pfizer deal started making rounds on the bourses, but it is now quite evident that the dalal street has given a ok to the deal.